HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adjuvant chemotherapy in a pregnant patient with endodermal sinus tumor of the ovary.

Abstract
The development of germ cell carcinoma of the ovary during pregnancy is a rare occurrence. Recent advances in chemotherapy have improved significantly the prognosis for patients with early stage disease. Use of cytotoxic agents in pregnancy traditionally has been avoided because of possible teratogenic effects. We describe a pregnant patient who was found to have endodermal sinus tumor of the ovary, stage I, at 13 weeks gestation. She received five courses of adjuvant VAC chemotherapy, beginning with her 17th week of gestation, prior to delivery of a normal infant at term. After an additional seven courses of chemotherapy, a second-look laparotomy revealed no evidence of disease. The infant is developmentally normal at 1 year. A comprehensive review of the literature describing use of chemotherapeutic agents in pregnancy is presented.
AuthorsS A Metz, T G Day, S H Pursell
JournalGynecologic oncology (Gynecol Oncol) Vol. 32 Issue 3 Pg. 371-4 (Mar 1989) ISSN: 0090-8258 [Print] United States
PMID2920961 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage, adverse effects)
  • Doxorubicin (administration & dosage, adverse effects)
  • Female
  • Humans
  • Mesonephroma (drug therapy, surgery)
  • Ovarian Neoplasms (drug therapy, surgery)
  • Pregnancy
  • Pregnancy Complications, Neoplastic (drug therapy, surgery)
  • Vincristine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: